Overview

Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this trial is to assess the safety and tolerability of 20 µg/kg and 25 µg/kg liraglutide in healthy Japanese male subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Liraglutide